688176 亞虹醫藥
按盤價 
14.730 +2.030 (+15.984%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -16.286 | -23.486 | -17.628 | -15.524 | -8.525 |
| 總資產報酬率 ROA (%) | -12.222 | -19.455 | -15.821 | -14.545 | -8.256 |
| 投入資產回報率 ROIC (%) | -13.052 | -20.695 | -16.609 | -15.076 | -8.472 | 邊際利潤分析 |
| 銷售毛利率 (%) | 74.247 | 74.033 | 75.540 | 78.998 | 73.022 |
| 營業利潤率 (%) | -156.208 | -154.563 | -190.415 | -2,937.490 | -948,649.406 |
| 息稅前利潤/營業總收入 (%) | -154.692 | -154.807 | -199.958 | -3,197.334 | -1,037,721.275 |
| 淨利潤/營業總收入 (%) | -157.668 | -156.157 | -191.504 | -2,914.455 | -944,804.606 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.487 | 103.654 | 105.337 | 107.943 | 125.221 |
| 價值變動淨收益/利潤總額(%) | -5.309 | -5.040 | -6.322 | -6.324 | -23.476 |
| 營業外收支淨額/利潤總額(%) | 0.857 | 1.172 | 0.773 | -0.623 | -0.932 | 償債能力分析 |
| 流動比率 (X) | 6.453 | 4.378 | 7.769 | 12.816 | 34.217 |
| 速動比率 (X) | 6.351 | 4.324 | 7.739 | 12.808 | 34.182 |
| 資產負債率 (%) | 27.776 | 24.031 | 11.364 | 9.213 | 3.583 |
| 帶息債務/全部投入資本 (%) | 18.278 | 15.703 | 3.676 | 3.065 | -0.130 |
| 股東權益/帶息債務 (%) | 427.041 | 522.376 | 2,548.554 | 3,089.060 | -76,383.985 |
| 股東權益/負債合計 (%) | 263.916 | 318.815 | 779.598 | 984.723 | 2,690.805 |
| 利息保障倍數 (X) | -53.983 | -97.445 | 24.812 | 11.500 | 10.607 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 139.535 | 102.927 | 61.240 | 113.751 | 141.021 |
| 存貨周轉天數 (天) | 105.573 | 69.427 | 27.202 | 274.394 | 168,675.349 |
| 備註： | 即時報價更新時間為 21/09/2026 16:07 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
